نتایج جستجو برای: recombinant factor

تعداد نتایج: 930017  

Journal: :iranian journal of blood and cancer 0
p eshghi pediatric congenital hematologic disorders research center, mofid children’s hospital, shahid beheshti university of medical sciences, tehran, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) h abolghasemi pediatric congenital hematologic disorders research center, mofid children’s hospital, shahid beheshti university of medical sciences, tehran, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) f malek pediatric congenital hematologic disorders research center, mofid children’s hospital, shahid beheshti university of medical sciences, tehran, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) m naderi zahedan university of medical sciences, zahedan, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی زاهدان (zahedan university of medical sciences) y panahi baqiyatallah university of medical sciences, tehran, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی بقیه الله (baqiyatallah university of medical sciences) b habibpanah comprehensive care center for children with hemophilia, mofid children’s hospital, shahid beheshti university of medical sciences, tehran, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences)

background: considering the increasing number of patients with hemophilia and infrastructure requirements for a comprehensive approach, development of a recombinant factor has become a milestone. the objective of this study was to assess the safety, efficacy and non inferiority of safacto (recombinant factor viii) compared with plasma-derived factor in the treatment of hemophilia a. methods: 10 ...

Journal: :avicenna journal of medical biochemistry 0
fatemeh ebrahimzadeh research center for molecular medicine, department of molecular medicine and genetics, hamadan university of medical sciences, hamadan, ir iran yeganeh talebkhan department of biotechnology, biotechnology research center, pasteur institute of iran, tehran, ir iran hassan mirzahoseini department of biotechnology, biotechnology research center, pasteur institute of iran, tehran, ir iran ghasem barati research center for molecular medicine, department of molecular medicine and genetics, hamadan university of medical sciences, hamadan, ir iran massoud saidijam research center for molecular medicine, department of molecular medicine and genetics, hamadan university of medical sciences, hamadan, ir iran; research center for molecular medicine, department of molecular medicine and genetics, school of medicine, hamadan university of medical sciences, hamadan, ir iran. tel: +98-9121324616, fax: +98-8138380464

results cloning was confirmed by pcr and restriction digestion. rt-pcr and sds-page represented expression of kgf in e. coli. the optimized expression was achieved 16 hours after induction with 0.3 mm iptg at 37°c in luria broth (lb) containing kanamycin. the 18 kda protein was confirmed by western blotting, using anti-his antibodies. conclusions the result of the present study indicated that e...

Journal: :international journal of advanced biological and biomedical research 2014
mehdi taghizadeghan majid norouzi saeid aharizad

to identifying of the high yielding wheat lines with optimal characteristics and to determine the traits which could be used as the selection index for increasing of grain yield, 40 recombinant inbred lines derived from a cross between norstar and zagros cultivars were evaluated in a randomized complete block design with three replications. the measured characters consisted of peduncle weight, ...

Journal: :anesthesiology and pain medicine 0
narges payani anesthesiology research center, shahid beheshti university of medical sciences, tehran, iran mahnoosh foroughi cardiovascular research center, shahid beheshti university of medical sciences, tehran, iran ali dabbagh anesthesiology research center, shahid beheshti university of medical sciences, tehran, iran; anesthesiology research center, shahid beheshti university of medical sciences, tehran, iran. tel/fax: +98-2122432572

conclusions our study demonstrated the efficacy of rfviia in controlling postoperative bleeding in redo cardiac valve surgeries regarding subsequent blood loss and transfusion requirement; however, outcome results remains to be defined. results study groups showed no difference regarding baseline variables. three patients in rfviia group (16.67%) and 13 in placebo group (72.23%) received blood ...

Journal: :Medical Journal Armed Forces India 2009

B Habibpanah, E Fatohlahzadeh, F Gorji, P Eshghi, Y Panahi, F Malek , H Abolghasemi , M Naderi ,

Background: Considering the increasing number of patients with hemophilia and infrastructure requirements for a comprehensive approach, development of a recombinant factor has become a milestone. The objective of this study was to assess the safety, efficacy and non inferiority of Safacto (Recombinant factor VIII) compared with plasma-derived factor in the treatment of hemophilia A. Methods: 10 ...

Journal: :Seminars in Thrombosis and Hemostasis 2010

Transforming growth factor beta (TGFβ1, β2, and β3) are 25 kDa disulfide-linked homodimers that regulate many aspects of cellular functions, consist of proliferation, differentiation, adhesion and extracellular matrix formation. TGFβs mediate their biological activities by binding of growth factor ligand to two related, functionally distinct, single-pass transmembrane receptor kinases, known as...

Alireza Abdollahi, Gholamreza Toogeh, Hassan Abolghasemi Katayoon Karimi Mohammadreza Managhchi Mohammadreza Shaverdi-niasari Neda Emran Peyman Eshghi, Samin Roostaei

Background: Recombinant activated factor VII induces hemostasis in patients with coagulopathy disorders. AryoSeven™ as a safe Iranian Recombinant activated factor VII has been available on our market. This study was performed to establish the safety of AryoSeven on patients with coagulopathy disorder. Methods: This single-center, descriptive,...

Journal: :JAMA Internal Medicine 2021

Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With COVID-19 and Lymphopenia

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید